Zobrazeno 1 - 10
of 135
pro vyhledávání: '"Edgar, Faber"'
Autor:
Petra Belohlavkova, Daniela Zackova, Hana Klamova, Edgar Faber, Michal Karas, Lukas Stejskal, Eduard Cmunt, Olga Cerna, Ivana Jeziskova, Katerina Machova Polakova, Pavel Zak, Tereza Jurkova, Marika Chrapava, Jiri Mayer
Publikováno v:
Cancer Medicine, Vol 13, Iss 17, Pp n/a-n/a (2024)
Abstract Background To evaluate the outcomes of first‐line imatinib versus nilotinib treatment for chronic myeloid leukemia in the chronic phase (CML‐CP) in real‐world clinical practice. Methods A propensity score analysis was performed to elim
Externí odkaz:
https://doaj.org/article/a3f1e095df1743329fc066dd5daac827
Autor:
Martin Cernan, Tomas Szotkowski, Jaromir Hubacek, Milan Kolar, Edgar Faber, Karel Indrak, Tomas Papajik
Publikováno v:
Biomedical Papers, Vol 167, Iss 3, Pp 236-245 (2023)
Background. Infectious complications during induction chemotherapy of acute myeloid leukaemia are very common. Prophylactic use of antibiotics however is an ongoing challenge in this situation due to bacterial multi-drug resistance. The aim of this s
Externí odkaz:
https://doaj.org/article/3f4604fbe33c4c9797523bde05b76384
Autor:
Lukas Semerad, Daniela Žáčková, Petra Belohlavkova, Jaroslava Voglova, Pavel Žák, Edgar Faber, Tomas Papajik, Ivana Skoumalova, Michal Karas, Pavel Jindra, Hana Klamová, Cyril Salek, Dana Srbová, Hana Zizkova, Lukas Stejskal, Olga Cerna, Eduard Cmunt, Petra Cicatkova, Anezka Kvetkova, Tomas Hornak, Ivana Jeziskova, Tomas Jurcek, Barbora Weinbergerová, Jirina Prochazkova, Katerina Machova Polakova, Adam Svobodnik, Radka Stepanova, Jiri Mayer
Publikováno v:
HemaSphere, Vol 7, p e70530bf (2023)
Externí odkaz:
https://doaj.org/article/e7c94ed4ac6546329523a51b5039e6a2
Autor:
Carlos Cuesta-Mateos, Patricia Fuentes, Alexandra Schrader, Raquel Juárez-Sánchez, Javier Loscertales, Tamara Mateu-Albero, Lorena Vega-Piris, Marina Espartero-Santos, Ana Marcos-Jimenez, Blanca Andrea Sánchez-López, Yaiza Pérez-García, Dennis Jungherz, Sebastian Oberbeck, Linus Wahnschaffe, Anna Kreutzman, Emma I. Andersson, Satu Mustjoki, Edgar Faber, Ana Urzainqui, Manuel Fresno, Kostantino Stamatakis, Arantzazu Alfranca, Fernando Terrón, Marco Herling, María Luisa Toribio, Cecilia Muñoz-Calleja
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-17 (2020)
Abstract T-cell prolymphocytic leukemia (T-PLL) is a poor prognostic disease with very limited options of efficient therapies. Most patients are refractory to chemotherapies and despite high response rates after alemtuzumab, virtually all patients re
Externí odkaz:
https://doaj.org/article/de532df98e854abe8a204e17060b7cf5
Autor:
Lucia Vráblová, Vladimír Divoký, Pavla Kořalková, Kateřina Machová Poláková, Eva Kriegová, Romana Janská, Jan Grohmann, Milena Holzerová, Tomáš Papajík, Edgar Faber
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 3, p 2050 (2023)
The treatment outcome in patients with chronic myeloid leukaemia (CML) in blast crisis (BC) is unsatisfactory despite the use of allogeneic stem cell transplantation (ASCT). Moreover, in some patients ASCT is contraindicated, with limited treatment o
Externí odkaz:
https://doaj.org/article/a737d387330d491f96f3a793bafbcf86
Autor:
Lucie Sochorcova, Katarina Hlusickova Kapralova, Jana Fialova Kucerova, Dagmar Pospisilova, Daniela Prochazkova, Ondrej Jahoda, Simona Kurekova, Barbora Kralova, Martina Divoka, Jana Navratilova, Jirina Manakova, Eva Kriegova, Karel Indrak, Edgar Faber, Vladimir Divoky, Monika Horvathova
Publikováno v:
British Journal of Haematology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb11de932a2913cff24d20cfae9bc5f5
https://doi.org/10.1111/bjh.18891
https://doi.org/10.1111/bjh.18891
Autor:
Katerina Machova Polakova, Ali Albeer, Vaclava Polivkova, Monika Krutska, Katerina Vlcanova, Alice FABARIUS, Hana Klamova, B Spieß, Cornelius Waller, Tim Bruemmendorf, Jolanta Dengler, Volker Kunzmann, Andreas Burchert, Petra Belohlavkova, Satu Mustjoki, Edgar Faber, Jiri Mayer, Daniela Zackova, Panayiotis Panayiotidis, Johan Richter, Henrik Hjorth-Hansen, Magdalena Płonka, Elżbieta Szczepanek, Monika Szarejko, Grażyna Bober, Iwona Hus, Olga Grzybowska-Izydorczyk, Janusz Kloczko, Edyta Paczkowska, Joanna Niesiobędzka-Krężel, Krzysztof Giannopoulos, Francois-Xavier Mahon, Tomasz Sacha, Susanne Saussele, Markus Pfirrmann
Membrane transporters are important determinants of drug bioavailability. Their expression and activity affect the intracellular drug concentration in leukemic cells impacting response to therapy. Pharmacogenomics represents genetic markers that refl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6488731f910555df7d7fa196a4610f36
https://doi.org/10.21203/rs.3.rs-2770615/v1
https://doi.org/10.21203/rs.3.rs-2770615/v1
Autor:
Adam Kuba, Tomas Szotkowski, Peter Rohon, Edgar Faber, Peter Turcsanyi, Jaromir Hubacek, Milena Holzerova, Vojtech Prasil, Marie Jarosova, Karel Indrak
Publikováno v:
Biomedical Papers, Vol 159, Iss 2, Pp 294-298 (2015)
Background: Acute promyelocytic leukaemia (APL) is a subtype of acute myeloid leukaemia with high curability rates. However, it is often accompanied by severe coagulopathy and bleeding risk and thus represents a potentially fatal haematological emerg
Externí odkaz:
https://doaj.org/article/ea6b0196dc764f169dc3667274f75947
Autor:
Annamaria Brioli, Elza Lomaia, Christian Fabisch, Tomasz Sacha, Hana Klamová, Elena Morozova, Aleksandra Golos, Philipp Ernst, Ulla Olsson-Strömberg, Jiri Mayer, Franck E. Nicolini, Han Bao, Fausto Castagnetti, Elzbieta Patkowska, Klaus Hirschbühl, Edyta Paczkowska, Anne Parry, Astghik Voskanyan, Susanne Saussele, Georg-Nikolaus Franke, Alexander Kiani, Edgar Faber, Krzysztof Lewandowski, Stefan W. Krause, Elke Dammann, Peter Anhut, Justyna Gil, Thomas Südhoff, Sonja Heibl, Markus Pfirrmann, Andreas Hochhaus, Michael Lauseker
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c876a3d0fbdd569aabab492634e9fb8a
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/99716
https://opus.bibliothek.uni-augsburg.de/opus4/frontdoor/index/index/docId/99716
Autor:
Adam, Kuba, Ludek, Raida, Svetlana, Brychtova, Patrik, Flodr, Frantisek, Mrazek, Eva, Kriegova, Edgar, Faber, Tomas, Papajik
Publikováno v:
Transplant immunology. 76
Lower gastrointestinal (GI) graft versus host disease (GVHD) represents a severe complication in allogeneic hematopoietic stem cell transplant (HSCT) recipients with high rates of transplant-related mortality. Deregulated innate immunity reactions ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::36383ed1c03677067cb4979b1473b3cb
https://pubmed.ncbi.nlm.nih.gov/36470572
https://pubmed.ncbi.nlm.nih.gov/36470572